The free dividend tracker to help you grow your wealth. Link your brokerage accounts and MerryDiv automatically syncs your holdings and dividends.
Data last updated: Jul 13, 2026
Snapshot (as of Jul 13, 2026): Amgen Inc. (AMGN) pays a $9.80 annual dividend ($2.52 quarterly), yielding 2.72% at $360.45/share. Next ex-dividend date 2026-05-15. 13+ consecutive years of dividend growth. Source: Yahoo Finance, aggregated by MerryDiv.
Dividend Yield: 2.72%
Annual Dividend: $9.80 per share
Payout Ratio: 66.7%
Ex-Dividend Date: 2026-05-15
Dividend Frequency: quarterly
Sector: Healthcare
Years of Dividend History: 16
Amgen Inc. dividend income comes from one of the largest biotechnology companies in the world, built on a portfolio of medicines spanning oncology, cardiovascular disease, and inflammatory conditions. AMGN currently pays $9.80 per share annually, with dividends distributed quarterly and the next ex-dividend date set for May 15, 2026. The current yield stands at 2.62%. With a beta of 0.403, Amgen Inc. stock moves well below the broader market, which appeals to income investors who prioritize low volatility over maximum yield.
Amgen Inc. pays out 66.7% of earnings as dividends, a payout ratio classified as elevated (60–75%). That level is supported by a broad product lineup with recurring demand across chronic conditions, including Repatha for cardiovascular risk reduction, Prolia for osteoporosis, and Enbrel for inflammatory diseases. Amgen Inc. dividend safety faces its main pressure from that payout ratio sitting near the upper end of a sustainable range, leaving less room to absorb earnings disruptions without affecting the dividend.
Amgen Inc. dividend history shows a CAGR of 15.6% per year from 2012 to 2025. The per-share payment grew from $1.44 to $9.52 over that period (2026 data is partial and excluded from this calculation). The smallest annual increase in the window was 5.6% in 2024, a notable step down from the double-digit raises that defined most of the prior decade.
| Period | CAGR | From | To |
|---|---|---|---|
| 3-Year | +7.1% | $7.76 (2022) | $9.52 (2025) |
| 5-Year | +8.3% | $6.40 (2020) | $9.52 (2025) |
| 10-Year | +11.7% | $3.16 (2015) | $9.52 (2025) |
Amgen Inc. fits dividend investors who want meaningful income from a large biotechnology business with a long record of annual increases. The yield sits in the moderate (2–4%) range at 2.62%, above its 5-year average of 2.24%, which reflects a higher payout relative to recent norms. Thirteen consecutive years of dividend increases back that yield with a real growth record, though the 66.7% payout ratio means the dividend consumes a substantial share of earnings. What an investor gets here is above-average yield for the sector paired with a growth rate that has slowed in recent years. The trade-off is limited cushion if earnings come under pressure.
| Payment Date | Amount per Share |
|---|---|
| 2026-05-15 | $2.5200 |
| 2026-02-13 | $2.5200 |
| 2025-11-21 | $2.3800 |
| 2025-08-22 | $2.3800 |
| 2025-05-16 | $2.3800 |
| 2025-02-14 | $2.3800 |
| 2024-11-18 | $2.2500 |
| 2024-08-16 | $2.2500 |
| 2024-05-16 | $2.2500 |
| 2024-02-15 | $2.2500 |
| Year | Total Dividends |
|---|---|
| 2026 | $5.0400 |
| 2025 | $9.5200 |
| 2024 | $9.0000 |
| 2023 | $8.5200 |
| 2022 | $7.7600 |
Project income from AMGN with the AMGN dividend calculator or track your full portfolio with the dividend tracker.